Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Chantal Belorgey"'
Autor:
Denis Lacombe, Ad Schuurman, Jessica Imbert, Jordi Llinares Garcia, Valentina Strammiello, Ansgar Hebborn, Flora Giorgio, Edith Frénoy, Giovanni Tafuri, Niklas Hedberg, Ingvil von Mehren Sæterdal, Anne Willemsen, Chantal Belorgey, C. Favaretti, Zoe Garrett, Daniel Widmer, Anna Lefevre Skjöldebrand, Elena Petelos, François Houÿez, Marcus Guardian
Publikováno v:
International Journal of Technology Assessment in Health Care. 36:191-196
The European Network for Health Technology Assessment (EUnetHTA) organizes an annual Forum with stakeholders to receive feedback on its activities, processes, and outputs produced. The fourth edition of the EUnetHTA Forum brought together representat
Autor:
Marie-Pierre Chauvet, Luc Ceugnart, A. Lesur, Stéphanie Besnard, Christophe Hennequin, Bruno Cutuli, Alain Fourquet, Antoine Arnaud, Patricia de Cremoux, Audrey Lesieur, Philippe Bertheau, Christine Tunon de Lara, Charles Coutant, Véronique Boute, Chantal Belorgey, Anne Vincent-Salomon, Laurent Lévy, L. Boulanger
Publikováno v:
Annales de Pathologie. 36:166-173
Resume Objectif Depuis les dernieres recommandations nationales elaborees par l’Institut national du cancer (INCa) et la Societe francaise de senologie et de pathologie mammaire (SFSPM) sur l’ensemble de la prise en charge diagnostique et therape
Autor:
Christian Thuillez, Chantal Belorgey, Anne d'Andon, Margaret Galbraith, François Meyer, Chantal Guilhaume, Judith Fernandez
Publikováno v:
International Journal of Technology Assessment in Health Care. 34:55-56
Introduction:A recent article reported a high level of commonality across European Health Technology Assessment bodies’ (HTABs) positions in former parallel scientific advice procedure. Since 2017, the EUnetHTA joint action 3 (JA3) offers a new ear
Publikováno v:
International Journal of Technology Assessment in Health Care. 34:73-74
Introduction:More and more software programs, including those with medical device status, are coming into the market that aim to facilitate management of diabetic patients. In France, their coverage requires a positive opinion from the French Nationa
Publikováno v:
International Journal of Technology Assessment in Health Care. 34:93-94
Introduction:To stay at home, have social interaction, or work, people experiencing urinary retention or uncontrolled urine or feces leakages need specific medical devices (MDs). In France, the MDs used to be covered by the health insurance system if
Autor:
Camille Thomassin, Judith Fernandez, Mathilde Grande, Christian Thuillez, Anne d'Andon, Chantal Belorgey
Publikováno v:
International Journal of Technology Assessment in Health Care. 35:30-30
IntroductionThe French health technology assessment (HTA) body, Haute Autorité de la Santé (HAS), started to provide early advice on evidence generation plans to pharmaceutical manufacturers in 2010. It became an official mission in 2016. Requests
Autor:
Bruno, Cutuli, Christine, Tunon De Lara, Antoine, Arnaud, Philippe, Bertheau, Loïc, Boulanger, Véronique, Boute, Luc, Ceugnart, Marie-Pierre, Chauvet, Charles, Coutant, Patricia, De Cremoux, Alain, Fourquet, Christophe, Hennequin, Audrey, Lesieur, Anne, Lesur, Laurent, Lévy, Anne, Vincent-Salomon, Stéphanie, Besnard, Chantal, Belorgey
Publikováno v:
Annales de pathologie. 36(3)
Since the last guidelines published by the French National Cancer Institute (INCa) and the learning society "Société française de sénologie et de pathologie mammaire (SFSPM)" in 2009 about diagnosis and management of ductal carcinoma in situ, new
Autor:
Laurent Becquemont, Régis Bordet, Dominic Cellier, Marc Bardou, Philippe Beaune, Chantal Belorgey, Frédéric Bibeau, Jean-Pierre Boissel, Soizic Courcier, Frédérique De Broucker, Jacques Demotes-Mainard, Isabelle Diaz, Jean-Yves Fagon, Danièle Girault, Sylvia Goni, Rémy Hanf, Marie-Annick Hermann, Patrick Mismetti, Monique Morali, Mira Pavlovic, Elena Perrin, Yannick Plétan, Christophe Sauce, Gilles Vassal
Publikováno v:
Therapies. 67:349-357
One of the challenges of the coming years is to personalize medicine in order to provide each patient with an individualized treatment plan. The three objectives of personalized medicine are to refine diagnosis, rationalize treatment and engage patie
Autor:
Laurent Becquemont, Régis Bordet, Dominic Cellier, Marc Bardou, Philippe Beaune, Chantal Belorgey, Frédéric Bibeau, Jean-Pierre Boissel, Soizic Courcier, Frédérique De Broucker, Jacques Demotes-Mainard, Isabelle Diaz, Jean-Yves Fagon, Danièle Girault, Sylvia Goni, Rémy Hanf, Marie-Annick Hermann, Patrick Mismetti, Monique Morali, Mira Pavlovic, Elena Perrin, Yannick Plétan, Christophe Sauce, Gilles Vassal
Publikováno v:
Therapies. 67:339-348
Resume La personnalisation de la medecine est un des enjeux des prochaines annees afin qu’a chaque patient corresponde une prise en charge individualisee. La medecine personnalisee a pour triple objectif : affiner le diagnostic, rationaliser la pri
Autor:
Aziza Ghazouani, Hubert Galmiche, Chantal Belorgey, Anne Lesquelen, Gregory Emery, Jacques Belghiti
Publikováno v:
International Journal of Technology Assessment in Health Care. 33:56-57
INTRODUCTION:Post-approval studies (PAS) constitute an important tool in medical devices (MD) assessment usually supported by registries. However, registries are often poorly designed or incomplete. The French health insurance databases are organized